期刊文献+

广西汉族TUBB3基因表达与非小细胞肺癌关联性的研究

Correlation analysis of TUBB3 expression and non-small cell lung cancer in patients of Han Nationality in Guangxi province
下载PDF
导出
摘要 目的探索广西地区非小细胞肺癌(NSCLC)汉族患者中,Ⅲ类β-微管蛋白(TUBB3)基因mRNA的表达及其临床预后意义。方法采用逆转录-聚合酶链反应(RT-PCR)方法检测60例肿瘤组织以及其中34例癌旁组织中TUBB3基因mRNA的表达。结果 TUBB3在癌及癌旁组织中的表达分别为16.7%和2.9%(P=0.053),TUBB3表达时,淋巴结转移高于无淋巴结转移(80.0%和13.5%,P=0.014)。其余临床特征未发现任何有统计学意义的相关性。结论 TUBB3mRNA在汉族非小细胞肺癌患者中阳性表达可能代表一个晚期事件。 Objective To investigate the expression of class 1][ ^-tubulin (TUBB3) and its clinical sig- nificance in patients of Han nationality with non-small cell lung cancer (NSCLC) in Guangxi province. Methods The mRNA expression of TUBB3 gene was examined in 60 tumor tissues and 34 adjacent tissue samples using semi-quantitative RT-PCR. Results The expression rate ofTUBB3 mRNA was 16.7% in tumor tissues and 2.9% in its adjacent tissues (P=0.053), which was higher in the tissues with metastasis of lymph nodes (80.0%) than that without metastasis of lymph nodes (13.5%), P=0.014. No statistical correlation between TUBB3 expression and other clinical features were found. Conclusion Positive expression of TUBB3 mRNA in the Hart nationality might indicate an advanced stage event.
出处 《海南医学》 CAS 2013年第2期163-165,共3页 Hainan Medical Journal
基金 广西科学研究与技术开发计划项目(编号:桂科攻10124001A-44)
关键词 非小细胞肺癌 TUBB3基因 逆转录-聚合酶链反应(RT-PCR) Non-small ceil lung cancer TUBB3 Reverse transcription polymerase chain reaction (RT-PCR)
  • 相关文献

参考文献7

  • 1Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in Non-Small-Cell lung cancer and Cisplatin-Based adjuvant chemo- therapy [J]. N Engl J Med, 2006, 355(10): 983-991.
  • 2Dumontet C, Isaac S, Souquet P J, et al. Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy [J]. Bull Cancer, 2005, 92(2): 25-30.
  • 3Liu H, Liang Y, Li Y, et al. Gene silencing of BAG-1 modulates apoptotic genes and sensitizes lung cancer cell lines to cisplatin-in- duced apoptosis [J]. Cancer Biol Ther, 2010, 9(10): 832-840.
  • 4Azuma If, Sasada T, Kawahara A, et al. Expression of ERCC1 and class HI beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel [J]. Lung Cancer, 2009, 64(3): 326-333.
  • 5Rosell R, Felip E. Predicting response to paclitaxel/carboplat- in-based therapy in non-small cell lung cancer [J]. Semin Oncol, 2001, 28(4 Suppl 14): 37-44.
  • 6Rosell R, Scagliotti G, Danenberg KD, et al. Transcripts in pretreat- merit biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer [J]. Oncogene, 2003, 22(23): 3548-3553.
  • 7Seve P, Mackey J, Isaac S, et al. Class m beta-tubulin expression in tumor ceils predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel [J]. Mol Cancer Ther, 2005, 4(12): 2001-2007.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部